 Your new post is loading...
 Your new post is loading...
|
Scooped by
Ed Rybicki
February 10, 2022 7:11 AM
|
Two case studies provide evidence that antihistamines may provide relief for people living with symptoms of long COVID-19 that impair daily functioning.
|
Scooped by
Ed Rybicki
February 10, 2022 7:10 AM
|
These results indicate that a history of diphtheria or tetanus vaccinations is associated with less severe manifestations of COVID-19. These vaccinations may protect against severe COVID-19 symptoms by stimulating the immune system.
|
Scooped by
Ed Rybicki
February 10, 2022 7:09 AM
|
By now, everyone knows about COVID-19. But do you know how it can affect your body?
|
Scooped by
Ed Rybicki
February 1, 2022 5:30 AM
|
The SARS-CoV-2 Omicron variant has multiple Spike (S) protein mutations1,2 that contribute to escape from antibody neutralization3–6 and reduce vaccine protection from infection7,8. The extent to which other components of the adaptive response such as T cells may still target Omicron and contribute to protection from severe outcomes is unknown. We assessed the ability of T cells to react with Omicron spike in participants who were vaccinated with Ad26.CoV2.S, BNT162b2, or unvaccinated convalescent COVID-19 patients (n=70). We found that 70-80% of the CD4+ and CD8+ T cell response to spike was maintained across study groups. Moreover, the magnitude of Omicron cross-reactive T cells was similar to Beta and Delta variants, despite Omicron harboring considerably more mutations. In Omicron-infected hospitalized patients (n=19), there were comparable T cell responses to ancestral spike, nucleocapsid and membrane proteins to those patients hospitalized in previous waves dominated by the ancestral, Beta or Delta variants (n=49). Thus, despite Omicron’s extensive mutations and reduced susceptibility to neutralizing antibodies, the majority of T cell responses, induced by vaccination or infection, cross-recognize the variant. It remains to be determined whether well-preserved T cell immunity to Omicron contributes to protection from severe COVID-19, and is linked to early clinical observations from South Africa and elsewhere9–12.
|
Scooped by
Ed Rybicki
February 1, 2022 3:14 AM
|
Adverse cardiac events are a common complication of viral and bacterial pneumonia. For over a century, it has been recognized that influenza infection promotes severe forms of pulmonary disease mai...
|
Scooped by
Ed Rybicki
February 1, 2022 3:13 AM
|
The U.K. is in the midst of its largest bird flu outbreak, with new cases of the H5N1 strain in captive birds reported almost daily.
|
Scooped by
Ed Rybicki
February 1, 2022 3:12 AM
|
The smartphone app uses a process known as SmaRT-LAMP to analyze a person’s saliva sample to determine if they have COVID-19 or the flu...
|
Scooped by
Ed Rybicki
February 1, 2022 2:58 AM
|
"The discovery of delta-valerobetaine gives a potential angle on how to manipulate our gut bacteria or our diets for health benefits."...
|
Scooped by
Ed Rybicki
January 31, 2022 8:33 AM
|
Cyclodextrin, which the FDA has approved as an ingredient in drugs, may be able to reduce the risk of dementia after stroke, according to new research.
|
Scooped by
Ed Rybicki
January 31, 2022 8:32 AM
|
Biden administration health officials on Wednesday outlined a long-term vision for a future in which the nation coexists with Covid-19 without living in crisis and facing disruption to normal life.
|
Scooped by
Ed Rybicki
January 31, 2022 8:30 AM
|
Latest cases – in a 68-year-old man and 55-year-old woman – are among a global spike in infections, triggering calls for more surveillance...
|
Scooped by
Ed Rybicki
January 31, 2022 8:29 AM
|
This study provides evidence that alphasatellites have a role in symptom modulation and suppress helper virus replication without any discernible effect on the replication of the associated betasatellite.
|
Scooped by
Ed Rybicki
January 31, 2022 8:28 AM
|
One expert said things were not as simple as just an employee getting dismissed because they were not vaccinated.
|
|
Scooped by
Ed Rybicki
February 10, 2022 7:11 AM
|
Emerging viral diseases of plants are recognised as a growing threat to global food security. However, little is known about the evolutionary processes and ecological factors underlying the emergence and success of viruses that have caused past epidemics.
|
Scooped by
Ed Rybicki
February 10, 2022 7:09 AM
|
A parody conspiracy theory called Birds Aren’t Real has spread widely online, aiming to puncture misinformation using absurdism. Could that work?
|
Scooped by
Ed Rybicki
February 10, 2022 7:08 AM
|
When a program for kids with autism moved online due to COVID, its success came as a surprise. In some cases, online therapy worked better, researchers say.
|
Scooped by
Ed Rybicki
February 1, 2022 3:15 AM
|
A booster shot of indigenously developed vaccine, Covaxin, after two doses is able to generate robust antibody responses and neutralise the Omicron (B...
|
Scooped by
Ed Rybicki
February 1, 2022 3:13 AM
|
New cases of highly pathogenic avian influenza (HPAI) in poultry have been reported in Benin, Ghana, Niger, Nigeria and Togo...
|
Scooped by
Ed Rybicki
February 1, 2022 3:12 AM
|
Malta will start to scrap a requirement for people to present a COVID-19 vaccination certificate for entry to restaurants and other venues from next month, Health Minister Chris Fearne said on Tuesday.
|
Scooped by
Ed Rybicki
February 1, 2022 3:11 AM
|
WASHINGTON (AP) — U.S. health regulators on Monday granted full approval to Moderna's COVID-19 vaccine, a shot that's already been given to tens of millions of Americans since its emergency authorization over a year ago.
|
Scooped by
Ed Rybicki
January 31, 2022 8:33 AM
|
The surfaces in hospital rooms where COVID-19 patients got care don't have enough living COVID-19 virus on them to spread the infection, research finds.
|
Scooped by
Ed Rybicki
January 31, 2022 8:32 AM
|
Abstract The productive replication of human influenza viruses is almost exclusively restricted to cells in the respiratory tract. However, a key aspect of the host response to viral infection is t...
|
Scooped by
Ed Rybicki
January 31, 2022 8:30 AM
|
Moderna confirmed that the first participants have been dosed with its experimental HIV vaccine, kicking off its Phase 1 study.
|
Scooped by
Ed Rybicki
January 31, 2022 8:29 AM
|
People with moderate or greater symptoms of depression were more likely to believe at least 1 of 4 false statements about COVID-19 vaccines, research finds.
|
Scooped by
Ed Rybicki
January 31, 2022 8:28 AM
|
Geminiviruses are a major threat to agriculture in tropical and subtropical regions of the world. Geminiviruses have small genome with limited coding capacity. Despite this limitation, these viruses have mastered hijacking the host cellular metabolism for their survival.
|